The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.

Saved in:

Bibliographic Details
Title:	The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
Authors:	Fischl, M A¹ (AUTHOR), Richman, D D (AUTHOR), Hansen, N (AUTHOR), Collier, A C (AUTHOR), Carey, J T (AUTHOR), Para, M F (AUTHOR), Hardy, W D (AUTHOR), Dolin, R (AUTHOR), Powderly, W G (AUTHOR), Allan, J D (AUTHOR)
Source:	Annals of Internal Medicine. 5/15/90, Vol. 112 Issue 10, p727-737. 11p.
Database:	Academic Search Ultimate

Description
ISSN:	00034819
DOI:	10.7326/0003-4819-112-10-727